BTAI- Bioxcel Therapeutics, Inc.

Name: Bioxcel Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Bioxcel Therapeutics, Inc. (BTAI) has 11 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. BTAI is classified in the Pharmaceuticals industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Miller Michael Patrick	17.0K	$20.1K	-
Dir	Mack David J.	17.0K	$20.1K	-
Dir	Laumas Sandeep	17.0K	$20.1K	-
Dir	Patni Rajiv	17.0K	$20.1K	-
Dir	Votruba Michal	17.0K	$20.1K	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Dec 16, 2024	Mehta Vimal92	CEO And President	Sale+OE	3,117	$0.36	$1,131.27	-2.5%	-64.9%	-71.1%
Dec 16, 2024	O'Neill Vincent86	See Remarks	Sale+OE	165	$0.35	$58.13	-0.8%	-64.9%	-71.1%
Dec 16, 2024	Steinhart Richard I87	Chief Financial Officer	Sale+OE	577	$0.36	$206.98	-1.4%	-64.9%	-71.1%
Dec 16, 2024	Rodriguez Javier87	See Remarks	Sale+OE	430	$0.36	$153.02	-0.9%	-64.9%	-71.1%
Dec 16, 2024	Yocca Frank88	Chief Scientific Officer	Sale+OE	430	$0.35	$151.82	-0.7%	-64.9%	-71.1%
Oct 3, 2024	Wiley Matthew T.82	Chief Commercial Officer	Sell	6,272	$0.55	$3,449.60	-24.8%	-28.7%	-71.3%
Oct 3, 2024	Rodriguez Javier87	See Remarks	Sell	6,863	$0.55	$3,774.65	-22.4%	-28.7%	-71.3%
Oct 3, 2024	Yocca Frank88	Chief Scientific Officer	Sell	7,175	$0.55	$3,946.25	-20.2%	-28.7%	-71.3%
Oct 3, 2024	Steinhart Richard I87	Chief Financial Officer	Sell	7,175	$0.55	$3,946.25	-26.1%	-28.7%	-71.3%
Oct 3, 2024	O'Neill Vincent86	See Remarks	Sell	5,556	$0.55	$3,055.80	-22.1%	-28.7%	-71.3%

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC